PMA device
Arterx Surgical Sealant
Baxter Healthcare Corporation · Sealant, Polymerizing (NBE, Class III) · First FDA decision Mar 1, 2013, newest Mar 1, 2013Surgical bleeding and hemostasis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
3
Naming "Arterx"
MAUDE reports
0
Brand "Arterx", since 2015
PubMed studies
2
Mentioning "Arterx"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Arterx Surgical Sealant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P100030 · Decided Mar 1, 2013 · 948 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Arterx", any status and sponsor, newest update first.
Tenaxis Medical, Inc.Not on our public-company list
NCT01957904 · 44 participants · Start Jun 2013 · Primary completion Sep 2013
Device: ArterX Surgical Sealant · For: Vascular Disease
Sites: Trier, Germany
Tenaxis Medical, Inc.Not on our public-company list
NCT02476318 · 32 participants · Start Jun 2007 · Primary completion Aug 2007
Device: ArterX Vascular Sealant · For: Vascular Disease
Sites: Cologne, Germany; Dresden, Germany; Ulm, Germany
- ArterX Surgical Sealant, A Randomized Prospective Multicenter TrialPivotal-lookingCompleted
Tenaxis Medical, Inc.Not on our public-company list
NCT00759681 · 217 participants · Start Sep 2008 · Primary completion Dec 2009
Device: ArterX Surgical Sealant; Gelfoam and Thrombin · For: Vascular Disease
Sites: Greenville, South Carolina
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Arterx", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NBE
198 reports: 117 malfunction, 80 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Baxter Preveleak Surgical Sealant, Product Codes: ADS201808Open, Classified
Z-0660-2024 · Started Dec 6, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).
Cause as FDA categorized it: Under Investigation by firm · Device type: Sealant, Polymerizing (NBE)
Mallinckrodt Manufacturing LLC
Z-2687-2017 · Started Oct 17, 2014 · Posted by FDA Jul 6, 2017
Reason given: Product was improperly labeled leading to improper storage.
Cause as FDA categorized it: Other · Device type: Sealant, Polymerizing (NBE)
Published research
The most relevant PubMed records for "Arterx"[tiab]. The summary above synthesizes these.
- Results from a First-in-Human Trial of a Novel Vascular Sealant.
Florek HJ, Brunkwall J, Orend KH, et al. · Front Surg · 2015
- A randomized prospective multicenter trial of a novel vascular sealant.
Stone WM, Cull DL, Money SR · Ann Vasc Surg · 2012Comparative Study, Multicenter Study
Other devices of this type
Also filed under product code NBE.
- PROGEL Pleural Air Leak SealantNeomend, Inc. · PMA 2022
- Coseal Surgical SealantBaxter Bio Science · PMA 2021
- Preveleak Surgical Sealant, Preveleak I 0-pack delivery tipsBaxter Healthcare Corporation · PMA 2023
- Tridyne Vascular SealantNeomend, Inc. · PMA 2021
- Ethicon Omnex Surgical SealantETHICON, Inc. · PMA 2014
- Neomend's Progel Pleural Air Leak SealantNeomend, Inc. · PMA 2011
- Coseal Surgical Sealant (Premixed)Angiotech Medical Device Technologies · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.